From visions of global leadership to an asset sale: where did it go wrong for Althea’s medical aspirations? by Steve Jones May 8, 2025May 8, 2025 With Althea calling time on its Australian pharma business and selling the assets to Tasmanian Botanics, […]
Althea committed to ‘transparency and corrective action’ after failure to lodge mandatory ASX notices by Steve Jones December 12, 2024December 12, 2024
